Comments
Indian Immunologicals Ltd (IIL) launched its paediatric dose of India’s first indigenous Hepatitis A vaccine, Havisure, on Thursday.
Hepatitis A is a highly contagious liver infection caused by the Hepatitis A virus, which predominantly affects children and can lead to severe health complications. Vaccination is the most cost-effective, yet efficient, method to prevent the disease.
“We are delighted to introduce the pediatric dose of Havisure, the first indigenously-developed Hepatitis A vaccine in India. IIL is the single-largest contributor to the self-sufficiency of vaccines in the country,’‘ K. Anand Kumar, Managing Director, IIL, said in a release on Thursday.
“The launch of Havisure reinforces IIL’s long-standing commitment to innovation and public health, solidifying its position as the only company in India to develop an indigenous Hepatitis A vaccine, available in both 0.5 ml and 1 ml dosage forms for paediatric and adult use, respectively,’‘ he added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.